Provided by Tiger Trade Technology Pte. Ltd.

Inovio Pharmaceuticals

1.25
-0.0300-2.34%
Pre-market: 1.19-0.0600-4.80%05:54 EDT
Volume:2.39M
Turnover:3.01M
Market Cap:128.75M
PE:-1.21
High:1.31
Open:1.30
Low:1.23
Close:1.28
52wk High:2.72
52wk Low:0.5632
Shares:103.00M
Float Shares:95.79M
Volume Ratio:0.79
T/O Rate:2.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0338
EPS(LYR):-1.8117
ROE:-409.87%
ROA:-84.23%
PB:29.45
PE(LYR):-0.69

Loading ...

Inovio Announces Pricing of $17.5 Million Public Offering

THOMSON REUTERS
·
Apr 02

BUZZ-U.S. STOCKS ON THE MOVE-Globalstar, Wingstop, US energy stocks

Reuters
·
Apr 02

BUZZ-Inovio falls after suspending stock sale program

Reuters
·
Apr 02

Inovio Pharmaceuticals Inc - Suspends and Terminates Atm Prospectus With Oppenheimer & Co. - SEC Filing

THOMSON REUTERS
·
Apr 02

Inovio plans underwritten public offering of common stock with Series A and B warrants

Reuters
·
Apr 02

Inovio Announces Proposed Public Offering

THOMSON REUTERS
·
Apr 02

Inovio to present hemophilia A DNA-encoded FVIII data at scientific conference

Reuters
·
Apr 01

Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Mar 31

Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Mar 28

Inovio Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Mar 26

Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Mar 24

Inovio reports pDFVIII DNA therapy corrects bleeding in hemophilia A mice

Reuters
·
Mar 24

Shareholders Sue Inovio Pharmaceuticals Over DNA Technology Claims

TIPRANKS
·
Mar 23

Inovio Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
Mar 21

Inovio Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Mar 19

Inovio’s Earnings Call: INO-3107 Drives 2026 Focus

TIPRANKS
·
Mar 18

Inovio Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Mar 17

Inovio Pharmaceuticals CEO and CFO face securities class action as control person defendants

Reuters
·
Mar 17